Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-09

FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Tramadol Hydrochloride Extended-Release submitted by Trigen Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (tramadol hydrochloride)

Snippet

SUPPL AP for TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (TRAMADOL HYDROCHLORIDE)